Cahour A, Debeire P, Parente J P, Hartmann L, Montreuil J
Biochim Biophys Acta. 1984 Nov 28;802(2):188-96. doi: 10.1016/0304-4165(84)90160-0.
The extent of glycans heterogeneity in a pathological human immunoglobulin M ZAJ has been studied on oligosaccharides released by hydrazinolysis from the purified glycoprotein. After reduction with NaB3H4, asparagine-linked carbohydrate chains were separated by affinity chromatography on concanavalin A-Sepharose into oligomannosidic and N-acetyllactosaminic types. Glycans of the oligomannosidic type were further fractionated by HPLC and those of the N-acetyllactosamine type by preparative high-voltage electrophoresis. The primary structure of the main oligosaccharides was investigated on the basis of micro-methylation analysis, mass spectrometry and sequential exo-glycosidase digestion. Glycans of the oligomannosidic type varied in size from Man5GlcNAc2 to Man9GlcNAc2. N-Acetyllactosaminic glycans were found of the biantennary, bisected-biantennary and triantennary types. They presented a higher degree of heterogeneity due to the presence of a variable number of NeuAc and fucose residues. The new structures we report here were in addition to the major biantennary one we previously described on the basis of methylation analysis and 500 MHz 1H-NMR spectroscopy (Cahour, A., Debeire, P., Hartmann, L., Montreuil, J., Van Halbeek, H. and Vliegenthart, J.F.G. (1984) FEBS Lett. 170, 343-349): NeuAc(alpha 2-6)Gal(beta 1-4)GlcNAc(beta 1-2)Man(alpha 1-3)[Gal(beta 1-4)Glc-NAc(beta 1-2)Man(alpha 1-6)]Man(beta 1-4)]Glc-NAc(beta 1-4) [Fuc(alpha 1-6)]GlcNAc.
已对从纯化糖蛋白经肼解释放的寡糖研究了病理性人免疫球蛋白M ZAJ中聚糖的异质性程度。用NaB3H4还原后,天冬酰胺连接的碳水化合物链通过伴刀豆球蛋白A-琼脂糖亲和层析分离为低聚甘露糖型和N-乙酰乳糖胺型。低聚甘露糖型聚糖通过高效液相色谱进一步分级,N-乙酰乳糖胺型聚糖通过制备型高压电泳分级。基于微甲基化分析、质谱和顺序外切糖苷酶消化研究了主要寡糖的一级结构。低聚甘露糖型聚糖大小从Man5GlcNAc2到Man9GlcNAc2不等。发现N-乙酰乳糖胺聚糖有双天线型、平分双天线型和三天线型。由于存在数量可变的NeuAc和岩藻糖残基,它们呈现出更高程度的异质性。我们在此报告的新结构是除了我们先前基于甲基化分析和500 MHz 1H-NMR光谱描述的主要双天线型结构之外的结构(Cahour, A., Debeire, P., Hartmann, L., Montreuil, J., Van Halbeek, H.和Vliegenthart, J.F.G. (1984) FEBS Lett. 170, 343 - 349):NeuAc(α2 - 6)Gal(β1 - 4)GlcNAc(β1 - 2)Man(α1 - 3)[Gal(β1 - 4)GlcNAc(β1 - 2)Man(α1 - 6)]Man(β1 - 4)]GlcNAc(β1 - 4) [Fuc(α1 - 6)]GlcNAc。